New data from Pfizer Inc. indicates that its COVID-19 vaccine is more stable than previously believed when stored -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators.

Pfizer said it submitted the data supporting this conclusion to the Food and Drug Administration, with the hope that the agency would allow for vaccine vials to be stored at these temperatures for a total of two weeks as an alternative or complement to storage in an ultra-low temperature freezer. Should FDA update its emergency use authorization for the Pfizer vaccine, it would broaden the number of sites where the vaccine could be administered.

Related News Articles

Headline
President Biden yesterday continued the national emergency for the COVID-19 pandemic beyond March 1. The renewed national emergency, along with the recently…
Headline
The AHA and eight other hospital organizations today urged Senate leaders to include additional COVID-19 relief funding for health care providers in the…
Headline
The Food and Drug Administration's Office of Minority Health and Health Equity today released two videos on COVID-19 vaccines and the importance of communities…
Headline
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines,…
Headline
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective. According to the…
Headline
President Biden today will sign an executive order to create more resilient and secure supply chains for critical and essential goods, the White House…